OTCM
FZMD
Market cap5mUSD
Jul 11, Last price
0.07USD
1D
0.00%
1Q
12.90%
Jan 2017
-56.25%
Name
Fuse Medical Inc
Chart & Performance
Profile
Fuse Medical, Inc. manufactures and distributes medical device implants in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 16,115 -13.57% | 18,645 -8.67% | |||||||
Cost of revenue | 5,382 | 19,322 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 10,734 | (678) | |||||||
NOPBT Margin | 66.61% | ||||||||
Operating Taxes | 23 | 24 | |||||||
Tax Rate | 0.22% | ||||||||
NOPAT | 10,711 | (701) | |||||||
Net income | 1,460 -52.88% | 3,098 -295.11% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 1,794 | 2,147 | |||||||
Long-term debt | 200 | 200 | |||||||
Deferred revenue | (2,650) | ||||||||
Other long-term liabilities | 4,193 | 7,486 | |||||||
Net debt | (856) | (633) | |||||||
Cash flow | |||||||||
Cash from operating activities | 444 | 35 | |||||||
CAPEX | (444) | ||||||||
Cash from investing activities | |||||||||
Cash from financing activities | (353) | (440) | |||||||
FCF | 10,662 | 840 | |||||||
Balance | |||||||||
Cash | 238 | 148 | |||||||
Long term investments | 2,612 | 2,833 | |||||||
Excess cash | 2,044 | 2,048 | |||||||
Stockholders' equity | (319) | (1,779) | |||||||
Invested Capital | 7,655 | 8,651 | |||||||
ROIC | 131.37% | ||||||||
ROCE | 146.32% | ||||||||
EV | |||||||||
Common stock shares outstanding | 77,860 | 77,860 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 10,865 | (540) | |||||||
EV/EBITDA | |||||||||
Interest | 221 | 171 | |||||||
Interest/NOPBT | 2.06% |